CardioNet, Inc. BEAT, the leading wireless medical technology company
with an initial focus on the diagnosis and monitoring of cardiac arrhythmias,
today announced the publication of a new clinical study that further supports
CardioNet's Mobile Cardiac Outpatient Telemetry (MCOT^TM) in detecting a high
rate of atrial fibrillation in cryptogenic stroke.
This new study, titled “Outpatient cardiac telemetry detects a high rate of
atrial fibrillation in cryptogenic stroke,” was authored by Daniel J Miller,
MD, et al, Henry Ford Hospital, Department of Neurology, and was published
online on October 24th in the Journal of the Neurological Sciences. The study
showed that MCOT^TM frequently detects paroxysmal atrial fibrillation in
patients with cryptogenic stroke and transient ischemic attack (TIA). This
study is confirmation of the value of MCOT^TM for monitoring patients with
cryptogenic stroke and TIA for atrial fibrillation, one potential and
treatable, cause of stroke.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in